Vikram Karnani's most recent trade in Collegium Pharmaceutical Inc was a trade of 8,983 Common Stock done at an average price of $47.3 . Disclosure was reported to the exchange on Nov. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium pharma Inc | Vikram Karnani | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.35 per share. | 12 Nov 2025 | 8,983 | 96,989 (0%) | 0% | 47.3 | 425,345 | Common Stock |
| Collegium pharma Inc | Vikram Karnani | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 130,344 | 130,344 | - | - | Stock Option (Right to Purchase) | |
| Collegium pharma Inc | Vikram Karnani | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 105,972 | 105,972 (0%) | 0% | 0 | Common Stock | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Sale of securities on an exchange or to another person at price $ 87.08 per share. | 22 Feb 2021 | 7,713 | 104,810 (0%) | 0% | 87.1 | 671,671 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Sale of securities on an exchange or to another person at price $ 88.45 per share. | 22 Feb 2021 | 645 | 104,165 (0%) | 0% | 88.4 | 57,050 | Ordinary Shares |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 14,512 | 14,512 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 3,931 | 3,931 | - | - | Performance Restricted Stock Units (PSUs) | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 1,965 | 113,394 (0%) | 0% | 0 | Ordinary Shares | |
| Horizon Therapeutics Plc | Vikram Karnani | EVP & President, International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.17 per share. | 17 Feb 2021 | 871 | 112,523 (0%) | 0% | 87.2 | 75,925 | Ordinary Shares |